MannKind Corporation (NASDAQ:MNKD) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 7, 2024 MannKind Corporation beats earnings expectations. Reported EPS is $0.05, ...
MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
MannKind Corp (MNKD) reports a 37% revenue increase, driven by Tyvaso DPI and Afrezza, while navigating market challenges and ...
MannKind (MNKD) Q3 2024 Earnings Call Transcript
MannKind (NASDAQ: MNKD) Q3 2024 Earnings Call Nov 07, 2024, 4:30 p.m. ET ...
MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update
MannKind will host a conference call and presentation webcast to discuss these results today at 4:30 p.m. Eastern Time. The webcast will be accessible via a link on MannKind’s website. A replay will ...
Yahoo Finance1mon
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ...
Collaboration and Services Revenue: $26 million in Q2 2024, a 132% increase over Q2 2023. Afrezza Net Revenue: $16 million in Q2 2024, a 20% increase over Q2 2023. V-GO Revenue: $4 million in Q2 2024, ...
Nasdaq1mon
MannKind Reports 30-week Results From Phase 4 INHALE-3 Study - Quick Facts
With the positive data received at both 17- and 30-weeks, the company continues to affirm that Afrezza is an important option for adult patients managing their diabetes. "The data from the ...